Stock Events

Stock Events

Personalis 

$18.38
83
+$1.50+8.89% Friday 20:00
+$0.09+0.48%Friday 23:55After hours

Statistics

Day High
18.42
Day Low
18.36
52W High
18.89
52W Low
4.65
Volume
74,214
Avg. Volume
-
Mkt Cap
1.96B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

10NovExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-0.3
-0.26
-0.22
-0.18
Expected EPS
-0.2596
Actual EPS
N/A

Financials

-116.69%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
69.65MRevenue
-81.27MNet Income

Analyst Ratings

15.17Average Price Target
The highest estimate is 16.25.
From 4 ratings within the last 6 months. This is not an investment recommendation.
Buy
25%
Hold
75%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow PSNL. It's not an investment recommendation.
NVIDIA
13
NVDA
Microsoft
11
MSFT
Apple
10
AAPL
Realty Income
10
O

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Illumina
ILMN
Mkt Cap28.82B
Illumina provides sequencing and array-based solutions for genetic and genomic analysis, competing directly in the genomics space with Personalis.
Pacific Biosciences of California
PACB
Mkt Cap357.46M
Pacific Biosciences offers long-read sequencing technologies, which compete with Personalis in the comprehensive genomic analysis market.
Guardant Health
GH
Mkt Cap21.1B
Guardant Health specializes in liquid biopsies and cancer diagnostics, competing with Personalis in the genomic cancer testing market.
Fulgent Genetics
FLGT
Mkt Cap510.68M
Fulgent Genetics offers comprehensive genetic testing, directly competing with Personalis in the space of genomic profiling and analysis.
Qiagen NV
QGEN
Mkt Cap8.87B
Qiagen is a provider of sample and assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical research, competing in the genomics and diagnostics market alongside Personalis.
Bionano Genomics
BNGO
Mkt Cap13.9M
Bionano Genomics provides tools for genomic analysis, including optical genome mapping solutions that compete with Personalis' genomic services.
Twist Bioscience
TWST
Mkt Cap7.44B
Twist Bioscience operates in the synthetic biology and genomics fields, offering products that compete with Personalis in the genomic research and clinical markets.
Adaptive Biotechnologies
ADPT
Mkt Cap3.94B
Adaptive Biotechnologies focuses on the immune-driven medicine space, offering genomic testing services that compete with Personalis in the personalized medicine and diagnostics field.

About

Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. The company' products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.
Show more...
CEO
Christopher Hall
Employees
260
Country
United States
ISIN
US71535D1063
WKN
000A2PLTK

Listings

F
DE
04X.F
STU
DE
04X.STU
MU
DE
04X.MU
XNAS
US
PSNL

0 Comments

Share your thoughts

FAQ

What is Personalis stock price today?▼
The current price of PSNL is $18.38 USD — it has increased by +8.89% in the past 24 hours. Watch Personalis stock price performance more closely on the chart.
What is Personalis stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Personalis stocks are traded under the ticker PSNL.
Is Personalis stock price growing?▼
PSNL stock has risen by +30.91% compared to the previous week, the month change is a +47.39% rise, over the last year Personalis has showed a +280.54% increase.
What is Personalis market cap?▼
Today Personalis has the market capitalization of 1.96B
When is the next Personalis earnings date?▼
Personalis is going to release the next earnings report on November 10, 2026.
What were Personalis earnings last quarter?▼
PSNL earnings for the last quarter are -0.3 USD per share, whereas the estimation was -0.26 USD resulting in a -13.92% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Personalis revenue for the last year?▼
Personalis revenue for the last year amounts to 69.65M USD.
What is Personalis net income for the last year?▼
PSNL net income for the last year is -81.27M USD.
How many employees does Personalis have?▼
As of August 22, 2026, the company has 260 employees.
In which sector is Personalis located?▼
Personalis operates in the Health & Wellness sector.
When did Personalis complete a stock split?▼
Personalis has not had any recent stock splits.
Where is Personalis headquartered?▼
Personalis is headquartered in FREMONT, United States.